stockrowBausch + Lomb Corporation
BLCO Healthcare Medical Instruments & Supplies
Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.
- Revenue
- +7.34%
- EPS
- +222.4%
- Free cash flow
- +182.5%
- Total debt
- +2.93%
Quarter to September 2026, against a year earlier
Follow BLCO
Alert me
Bausch + Lomb Corporation (BLCO) Gross margin
Bausch + Lomb Corporation's gross margin over the twelve months to 30 September 2026 was 62.6%, up 2.7 percentage points from fiscal 2025 (59.8%). Over the past ten years it has ranged from 59.7% (fiscal 2022) to 62.3% (fiscal 2020); the current reading is higher than 33% of that period. That is above the Medical Instruments & Supplies industry median of 53.6% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 59.8% | (1.12) |
| FY2024 | 60.9% | 0.53 |
| FY2023 | 60.4% | 0.71 |
| FY2022 | 59.7% | (1.35) |
| FY2021 | 61.0% | (1.30) |
| FY2020 | 62.3% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 64.7% | 2.45 |
| Jun 2026 | 62.2% | 1.03 |
| Mar 2026 | 61.2% | (0.89) |
| Dec 2025 | 62.1% | 1.87 |
| 19 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| ALGN Align Technology, Inc. compare | 69.1% |
| COO The Cooper Companies, Inc. compare | 65.9% |
| BLCO Bausch + Lomb Corporation | 62.6% |
| TFX Teleflex Incorporated compare | 54.9% |
| MMED MiniMed Group, Inc. compare | 53.6% |
| RGEN Repligen Corporation compare | 53.5% |
| MMSI Merit Medical Systems, Inc. compare | 49.4% |
| ATR AptarGroup, Inc. compare | 35.8% |
| AVTR Avantor, Inc. compare | 31.6% |
| Medical Instruments & Supplies industry median | 53.6% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on BLCO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement